vs
Side-by-side financial comparison of COLLEGIUM PHARMACEUTICAL, INC (COLL) and Oportun Financial Corp (OPRT). Click either name above to swap in a different company.
Oportun Financial Corp is the larger business by last-quarter revenue ($247.7M vs $205.4M, roughly 1.2× COLLEGIUM PHARMACEUTICAL, INC). COLLEGIUM PHARMACEUTICAL, INC runs the higher net margin — 8.3% vs 1.4%, a 6.9% gap on every dollar of revenue. On growth, COLLEGIUM PHARMACEUTICAL, INC posted the faster year-over-year revenue change (12.9% vs -1.3%). Over the past eight quarters, COLLEGIUM PHARMACEUTICAL, INC's revenue compounded faster (19.1% CAGR vs -0.5%).
Collegium Pharmaceutical, Inc. is a specialty pharmaceutical firm focused on developing and commercializing innovative, abuse-deterrent pain management therapies. Operating primarily in the U.S. market, it offers extended-release analgesics for chronic pain patients, serving providers across primary and specialty care segments.
Oportun Financial Corp is a US-based fintech firm that provides accessible, responsible financial services including personal loans, credit cards, and savings products to underserved low-to-moderate income consumers, many with limited or no credit history, leveraging proprietary AI underwriting to deliver fair terms while mitigating operational risk.
COLL vs OPRT — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $205.4M | $247.7M |
| Net Profit | $17.0M | $3.4M |
| Gross Margin | 62.5% | — |
| Operating Margin | 29.6% | 2.6% |
| Net Margin | 8.3% | 1.4% |
| Revenue YoY | 12.9% | -1.3% |
| Net Profit YoY | 35.3% | -61.0% |
| EPS (diluted) | $0.48 | $0.07 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $205.4M | $247.7M | ||
| Q3 25 | $209.4M | $238.7M | ||
| Q2 25 | $188.0M | $234.3M | ||
| Q1 25 | $177.8M | $235.9M | ||
| Q4 24 | $181.9M | $250.9M | ||
| Q3 24 | $159.3M | $250.0M | ||
| Q2 24 | $145.3M | $250.4M | ||
| Q1 24 | $144.9M | $250.5M |
| Q4 25 | $17.0M | $3.4M | ||
| Q3 25 | $31.5M | $5.2M | ||
| Q2 25 | $12.0M | $6.9M | ||
| Q1 25 | $2.4M | $9.8M | ||
| Q4 24 | $12.5M | $8.7M | ||
| Q3 24 | $9.3M | $-30.0M | ||
| Q2 24 | $19.6M | $-31.0M | ||
| Q1 24 | $27.7M | $-26.4M |
| Q4 25 | 62.5% | — | ||
| Q3 25 | 61.7% | — | ||
| Q2 25 | 57.7% | — | ||
| Q1 25 | 54.8% | — | ||
| Q4 24 | 54.0% | — | ||
| Q3 24 | 60.8% | — | ||
| Q2 24 | 62.5% | — | ||
| Q1 24 | 63.1% | — |
| Q4 25 | 29.6% | 2.6% | ||
| Q3 25 | 29.7% | 6.0% | ||
| Q2 25 | 18.7% | 4.3% | ||
| Q1 25 | 12.2% | 5.6% | ||
| Q4 24 | 20.9% | 89.6% | ||
| Q3 24 | 21.9% | -15.8% | ||
| Q2 24 | 32.7% | -19.6% | ||
| Q1 24 | 34.1% | -12.2% |
| Q4 25 | 8.3% | 1.4% | ||
| Q3 25 | 15.0% | 2.2% | ||
| Q2 25 | 6.4% | 2.9% | ||
| Q1 25 | 1.4% | 4.1% | ||
| Q4 24 | 6.9% | 200.1% | ||
| Q3 24 | 5.9% | -12.0% | ||
| Q2 24 | 13.5% | -12.4% | ||
| Q1 24 | 19.1% | -10.6% |
| Q4 25 | $0.48 | $0.07 | ||
| Q3 25 | $0.84 | $0.11 | ||
| Q2 25 | $0.34 | $0.14 | ||
| Q1 25 | $0.07 | $0.21 | ||
| Q4 24 | $0.36 | $0.26 | ||
| Q3 24 | $0.27 | $-0.75 | ||
| Q2 24 | $0.52 | $-0.78 | ||
| Q1 24 | $0.71 | $-0.68 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $386.7M | $105.5M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $301.7M | $390.1M |
| Total Assets | $1.7B | $3.3B |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $386.7M | $105.5M | ||
| Q3 25 | $285.9M | $104.6M | ||
| Q2 25 | $222.2M | $96.8M | ||
| Q1 25 | $197.8M | $78.5M | ||
| Q4 24 | $162.8M | $60.0M | ||
| Q3 24 | $120.0M | $71.8M | ||
| Q2 24 | $271.6M | $72.9M | ||
| Q1 24 | $318.0M | $69.2M |
| Q4 25 | $301.7M | $390.1M | ||
| Q3 25 | $274.8M | $383.9M | ||
| Q2 25 | $232.2M | $376.0M | ||
| Q1 25 | $234.4M | $366.1M | ||
| Q4 24 | $228.8M | $353.8M | ||
| Q3 24 | $234.3M | $327.6M | ||
| Q2 24 | $216.6M | $354.1M | ||
| Q1 24 | $222.2M | $382.0M |
| Q4 25 | $1.7B | $3.3B | ||
| Q3 25 | $1.6B | $3.2B | ||
| Q2 25 | $1.6B | $3.2B | ||
| Q1 25 | $1.6B | $3.2B | ||
| Q4 24 | $1.7B | $3.2B | ||
| Q3 24 | $1.6B | $3.3B | ||
| Q2 24 | $1.1B | $3.3B | ||
| Q1 24 | $1.1B | $3.3B |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $123.0M | $413.4M |
| Free Cash FlowOCF − Capex | $122.4M | — |
| FCF MarginFCF / Revenue | 59.6% | — |
| Capex IntensityCapex / Revenue | 0.3% | — |
| Cash ConversionOCF / Net Profit | 7.25× | 121.45× |
| TTM Free Cash FlowTrailing 4 quarters | $327.6M | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $123.0M | $413.4M | ||
| Q3 25 | $78.4M | $99.0M | ||
| Q2 25 | $72.4M | $104.5M | ||
| Q1 25 | $55.4M | $101.0M | ||
| Q4 24 | $84.6M | $393.5M | ||
| Q3 24 | $-9.0M | $108.5M | ||
| Q2 24 | $67.4M | $107.7M | ||
| Q1 24 | $61.9M | $85.9M |
| Q4 25 | $122.4M | — | ||
| Q3 25 | $78.3M | — | ||
| Q2 25 | $72.4M | — | ||
| Q1 25 | $54.6M | — | ||
| Q4 24 | $84.1M | — | ||
| Q3 24 | $-9.2M | — | ||
| Q2 24 | $67.1M | — | ||
| Q1 24 | $61.4M | — |
| Q4 25 | 59.6% | — | ||
| Q3 25 | 37.4% | — | ||
| Q2 25 | 38.5% | — | ||
| Q1 25 | 30.7% | — | ||
| Q4 24 | 46.2% | — | ||
| Q3 24 | -5.8% | — | ||
| Q2 24 | 46.2% | — | ||
| Q1 24 | 42.3% | — |
| Q4 25 | 0.3% | — | ||
| Q3 25 | 0.1% | — | ||
| Q2 25 | 0.0% | — | ||
| Q1 25 | 0.4% | — | ||
| Q4 24 | 0.3% | — | ||
| Q3 24 | 0.2% | — | ||
| Q2 24 | 0.2% | — | ||
| Q1 24 | 0.4% | — |
| Q4 25 | 7.25× | 121.45× | ||
| Q3 25 | 2.49× | 19.05× | ||
| Q2 25 | 6.05× | 15.20× | ||
| Q1 25 | 22.92× | 10.34× | ||
| Q4 24 | 6.75× | 45.04× | ||
| Q3 24 | -0.96× | — | ||
| Q2 24 | 3.44× | — | ||
| Q1 24 | 2.23× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
